Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Falls Along with Biotech Stocks

The BCW Index fell 2.2 percent for the trading week ended Tuesday, following the lead of the broader stock market and the Nasdaq Biotech Index in particular, which dropped 5.4 percent during the same period. The Nasdaq fell 4 percent for the week, while the Dow Jones Industrial Average declined 3 percent.

Shares of 12 of the 16 companies in the Index lost value during the tracking period. Molecular Devices led decliners with a drop of 7 percent, followed by Agilent and Waters, which fell 6.2 percent and 5.3 percent, respectively. Stratagene gained 7.9 percent for the week, leading the four stocks that gained ground during the week. It was the third week in a row that Stratagene shares climbed higher.

BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(July 18, 2006)
Last Price
(July 11, 2006)
% change
Agilent
A
28.30
30.18
-6.2
Applied Biosystems
ABI
32.45
32.70
-0.8
Beckman
BEC
53.75
56.44
-4.8
Bio-Rad
BIO
66.80
65.54
1.9
Bruker
BRKR
5.46
5.46
0.0
Fisher Scientific
FSH
70.58
71.38
-1.1
GE
GE
32.46
33.26
-2.4
Invitrogen
IVGN
61.42
62.37
-1.5
Millipore
MIL
61.77
62.61
-1.3
Molecular Devices
MDCC
28.03
30.15
-7.0
PerkinElmer
PKI
20.38
21.11
-3.5
Qiagen
QGEN
13.60
13.52
0.6
Sigma
SIAL
69.75
71.79
-2.8
Stratagene
STGN
7.55
7.00
7.9
Thermo
TMO
35.27
35.55
-0.8
Waters
WAT
41.69
44.04
-5.3
BCW Index Average
39.33
40.19
-2.2

 

 

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.